Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00043563
Status:
COMPLETED
Last Update Posted:
2015-12-16
First Post:
2002-08-09
Brief Title:
Cognitive Behavioral Treatment of Pediatric Trichotillomania
Sponsor:
University of Pennsylvania
Organization:
University of Pennsylvania
Study Overview
Official Title:
Cognitive Behavioral Treatment of Pediatric Trichotillomania
Status:
COMPLETED
Status Verified Date:
2015-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will compare the effectiveness of cognitive-behavior therapy CBT to a minimal attention control AC condition for treatment of pediatric trichotillomania TTM
Detailed Description:
TTM is a persistent impulse control disorder in which the individual acts on urges to pull out his or her own hair Onset typically occurs by adolescence and TTM is often associated with significant functional impairment and distress CBT is a type of psychotherapy designed to change problematic behaviors and thinking It includes self-monitoring of hair-pulling urges and homework assignments to practice the use of cognitive and behavioral strategies
Participants are assigned randomly to receive either CBT or AC for 8 weeks Participants assigned to CBT receive weekly 1-hour sessions of CBT for 8 weeks participants assigned to AC receive 6 telephone contacts and 2 in-person sessions for 8 weeks After 8 weeks CBT participants who respond to treatment enter Phase II which lasts an additional 8 weeks and includes 4 in-person maintenance sessions AC participants who are still symptomatic after 8 weeks are offered CBT
Participants are assigned randomly to receive either CBT or AC for 8 weeks Participants assigned to CBT receive weekly 1-hour sessions of CBT for 8 weeks participants assigned to AC receive 6 telephone contacts and 2 in-person sessions for 8 weeks After 8 weeks CBT participants who respond to treatment enter Phase II which lasts an additional 8 weeks and includes 4 in-person maintenance sessions AC participants who are still symptomatic after 8 weeks are offered CBT
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DSIR CT-S | US NIH GrantContract | None | httpsreporternihgovquickSearchR21MH061457 |
| R21MH061457 | NIH | None | None |